Growth • Edwards Lifesciences
EW
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
4,6%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
3,6%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
31,9%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
33,5%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
6,4%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
-14,4%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!